JP2023517722A5 - - Google Patents
Info
- Publication number
- JP2023517722A5 JP2023517722A5 JP2022555805A JP2022555805A JP2023517722A5 JP 2023517722 A5 JP2023517722 A5 JP 2023517722A5 JP 2022555805 A JP2022555805 A JP 2022555805A JP 2022555805 A JP2022555805 A JP 2022555805A JP 2023517722 A5 JP2023517722 A5 JP 2023517722A5
- Authority
- JP
- Japan
- Prior art keywords
- cocrystal
- group
- ray diffraction
- acid
- ylcarbamoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382194.7 | 2020-03-16 | ||
| EP20382194.7A EP3882240A1 (en) | 2020-03-16 | 2020-03-16 | Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid |
| PCT/EP2021/056506 WO2021185748A1 (en) | 2020-03-16 | 2021-03-15 | Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023517722A JP2023517722A (ja) | 2023-04-26 |
| JP2023517722A5 true JP2023517722A5 (enExample) | 2024-03-26 |
| JP7779846B2 JP7779846B2 (ja) | 2025-12-03 |
Family
ID=69953938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555805A Active JP7779846B2 (ja) | 2020-03-16 | 2021-03-15 | （１ｒ，３ｓ）－３－（５－シアノ－４－フェニル－１，３－チアゾール－２－イルカルバモイル）シクロペンタンカルボン酸の共結晶 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US12384754B2 (enExample) |
| EP (2) | EP3882240A1 (enExample) |
| JP (1) | JP7779846B2 (enExample) |
| KR (1) | KR20220154791A (enExample) |
| CN (1) | CN115298169B (enExample) |
| AU (1) | AU2021237686B2 (enExample) |
| BR (1) | BR112022018449A2 (enExample) |
| CA (1) | CA3171894C (enExample) |
| DK (1) | DK4121419T3 (enExample) |
| ES (1) | ES3002084T3 (enExample) |
| FI (1) | FI4121419T3 (enExample) |
| HR (1) | HRP20241515T1 (enExample) |
| HU (1) | HUE068886T2 (enExample) |
| LT (1) | LT4121419T (enExample) |
| MX (1) | MX2022011530A (enExample) |
| PL (1) | PL4121419T3 (enExample) |
| PT (1) | PT4121419T (enExample) |
| RS (1) | RS66214B1 (enExample) |
| SI (1) | SI4121419T1 (enExample) |
| WO (1) | WO2021185748A1 (enExample) |
| ZA (1) | ZA202211247B (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2331220B1 (es) * | 2007-10-02 | 2010-09-23 | Palobiofarma, S.L. | Nuevos compuestos como antagonistas de los receptores a1 de adenosina. |
| US8779146B2 (en) | 2010-04-28 | 2014-07-15 | Nuformix Limited | Cilostazol cocrystals and compositions |
| HRP20211104T1 (hr) | 2017-03-06 | 2021-10-15 | Palobiofarma, S.L. | Aminska sol (1r,3s)-3-(5-cijano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksilne kiseline |
-
2020
- 2020-03-16 EP EP20382194.7A patent/EP3882240A1/en not_active Withdrawn
-
2021
- 2021-03-15 AU AU2021237686A patent/AU2021237686B2/en active Active
- 2021-03-15 DK DK21710531.1T patent/DK4121419T3/da active
- 2021-03-15 PT PT217105311T patent/PT4121419T/pt unknown
- 2021-03-15 JP JP2022555805A patent/JP7779846B2/ja active Active
- 2021-03-15 CA CA3171894A patent/CA3171894C/en active Active
- 2021-03-15 ES ES21710531T patent/ES3002084T3/es active Active
- 2021-03-15 SI SI202130224T patent/SI4121419T1/sl unknown
- 2021-03-15 MX MX2022011530A patent/MX2022011530A/es unknown
- 2021-03-15 PL PL21710531.1T patent/PL4121419T3/pl unknown
- 2021-03-15 CN CN202180021708.3A patent/CN115298169B/zh active Active
- 2021-03-15 RS RS20241203A patent/RS66214B1/sr unknown
- 2021-03-15 FI FIEP21710531.1T patent/FI4121419T3/fi active
- 2021-03-15 US US17/906,367 patent/US12384754B2/en active Active
- 2021-03-15 HR HRP20241515TT patent/HRP20241515T1/hr unknown
- 2021-03-15 WO PCT/EP2021/056506 patent/WO2021185748A1/en not_active Ceased
- 2021-03-15 KR KR1020227035871A patent/KR20220154791A/ko active Pending
- 2021-03-15 BR BR112022018449A patent/BR112022018449A2/pt unknown
- 2021-03-15 EP EP21710531.1A patent/EP4121419B1/en active Active
- 2021-03-15 LT LTEPPCT/EP2021/056506T patent/LT4121419T/lt unknown
- 2021-03-15 HU HUE21710531A patent/HUE068886T2/hu unknown
-
2022
- 2022-10-13 ZA ZA2022/11247A patent/ZA202211247B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101611012B (zh) | 环烷基胺取代的异喹啉衍生物 | |
| TWI280244B (en) | Tropane derivatives | |
| JP2024537795A5 (enExample) | ||
| WO2000063208A1 (en) | Substituted imidazoles, their preparation and use | |
| CA2681431A1 (en) | Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of .beta.-secretase | |
| CA2068527A1 (en) | Muscarinic receptor antagonists | |
| CN110590749B (zh) | 吡啶胺基嘧啶衍生物甲磺酸盐的结晶形式及其制备和应用 | |
| JP2023541434A5 (enExample) | ||
| TW200831510A (en) | Compounds | |
| JPWO2008123582A1 (ja) | テトラヒドロイソキノリン化合物 | |
| EP3738955A1 (en) | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use | |
| WO2015199167A1 (ja) | 置換されたスピロピリド［１，２－ａ］ピラジン誘導体の製造方法および中間体 | |
| KR20130089089A (ko) | 트리사이클로 유도체 화합물의 신규한 결정형 산부가염 또는 이의 수화물 및 이의 제조방법 | |
| KR20100042671A (ko) | 신규 페닐아세테이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 ｔ-형 칼슘 이온 채널의 활성에 의해 유발되는 질환의 예방 또는 치료용 조성물 | |
| JP2022540678A5 (enExample) | ||
| JPH08507299A (ja) | ヒドロキシメチルフラザンカルボン酸誘導体及びこれを心臓血管系疾患の治療に使用する方法 | |
| TW200804327A (en) | Preventives/remedies for urinary disturbance | |
| KR102611847B1 (ko) | 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도 | |
| DE3807813A1 (de) | Neue benzocycloheptenderivate, diese verbindungen enthaltende arzneimittel und verfahren zu deren herstellung | |
| GB2419592A (en) | Process for the preparation of irbesartan hydrochloride | |
| CN107325052B (zh) | 一类具有抗癌活性的咪唑酯类化合物及其衍生物 | |
| FI4121419T3 (fi) | 1r,3s)-3-(5-syano-4-fenyyli-1,3-tiatsol-2-yylikarbamoyyli)syklopentaanikarboksylihapon kerakiteitä | |
| JP4881532B2 (ja) | ナフトアミジン系ウロキナーゼ阻害薬 | |
| JP5072965B2 (ja) | 高選択性および経口有効性ｃｏｘ−２インヒビターである３−置換−１，５−ジアリール−２−アルキルピロール | |
| JP2013542258A5 (enExample) |